In longstanding cases and in patients who have taken iron supplementation or received numerous blood transfusions, iron overload may be a significant problem.
The dyspnea risks following cangrelor treatment, suggest a common mechanism linking transfusion-related acute lung injury, dyspnea, and reversible platelet inhibition.
